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Summary
Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of
insulin signaling and a therapeutic target for type 2 diabetes
(T2DM). In this study, we have evaluated the role of PTP1B in the
development of aging-associated obesity, inflammation, and
peripheral insulin resistance by assessing metabolic parameters at
3 and 16 months in PTP1B) ⁄ ) mice maintained on mixed genetic
background (C57Bl ⁄ 6J · 129Sv ⁄ J).Whereas fatmass and adipocyte
size were increased in wild-type control mice at 16 months, these
parameters did not change with aging in PTP1B) ⁄ )mice. Increased
levels of pro-inflammatory cytokines, crown-like structures, and
hypoxia-inducible factor (HIF)-1awereobservedonly inadipose tis-
sue from 16-month-old wild-type mice. Similarly, islet hyperplasia
andhyperinsulinemiawere observed inwild-typemicewith aging-
associated obesity, but not in PTP1B) ⁄ ) animals. Leanness in 16-
month-old PTP1B) ⁄ ) mice was associated with increased energy
expenditure. Whole-body insulin sensitivity decreased in 16-
month-old control mice; however, studies with the hyperinsuline-
mic–euglycemic clamp revealed that PTP1B deficiency prevented
this obesity-related decreased peripheral insulin sensitivity. At a
molecular level, PTP1B expression and enzymatic activity were up-
regulated in liver and muscle of 16-month-old wild-type mice as
were the activation of stress kinases and the expression of p53.
Conversely, insulin receptor-mediated Akt ⁄ Foxo1 signaling was
attenuated in these aged control mice. Collectively, these data
implicate PTP1B in the development of inflammation and insulin
resistance associated with obesity during aging and suggest that
inhibition of this phosphatase by therapeutic strategiesmight pro-
tectagainstage-dependentT2DM.
Keywords: insulin resistance; type 2 diabetes; obesity; inflam-
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Introduction
Type 2 diabetes mellitus (T2DM) is the most common endocrine disorder
and occurs when insulin secretion can no longer compensate for insulin
resistance in peripheral tissues (Barbieri et al., 2001). Aging is associated
with the development of insulin resistance, providing a potential explana-
tion for the prevalence of T2DM in older adults (Fink et al., 1983), (Amati
et al., 2009). However, studies of the effects of aging on insulin action
have been complicated by the inability to discriminate between the influ-
ence of age itself and aging-associated changes in body composition.
Although the precise molecular mechanisms underlying insulin resis-
tance are not well defined, obesity is associated with a low-grade sys-
temic inflammation that contributes to defects in the critical nodes of
insulin signaling (Taniguchi et al., 2006). Several mechanisms modulate
insulin signaling, including down-regulation of the insulin receptor (IR),
serine phosphorylation or degradation of IRS proteins and dephosphory-
lation by specific protein tyrosine phosphatases, notably by protein tyro-
sine phosphatase (PTP) 1B. This phosphatase is a major negative regulator
of insulin and leptin sensitivity, acting by dephosphorylation of IR and lep-
tin receptor-associated Janus kinase 2 (Seely et al., 1996), (Zabolotny
et al., 2002). In vivo experiments have demonstrated that PTP1B-deficient
(PTP1B) ⁄ )) mice exhibit increased insulin sensitivity at 10–14 weeks of
age, resistance to weight gain on high-fat diet (HFD) and increased basal
metabolic rate (Elchebly et al., 1999), (Klaman et al., 2000). More recent
studies have reported that PTP1B re-expression in the liver of PTP1B) ⁄ )
mice attenuates enhanced insulin sensitivity (Haj et al., 2005). In contrast,
liver-specific deletion of PTP1B improves metabolic syndrome (MS) and
attenuates diet-induced endoplasmic reticulum (ER) stress (Delibegovic
et al., 2009). PTP1B expression is elevated in the liver of mice fed with
HFD, concomitant with increased levels of TNFa and CD68, two markers
of hepatic inflammation associated with steatosis (Zabolotny et al.,
2008). In humans, PTP1B polymorphisms are associated with insulin
resistance, obesity, and other characteristics of MS in some populations
(Kipfer-Coudreau et al., 2004). These studies reinforce the importance of
the development of PTP1B inhibitors as promising drugs for the treatment
of T2DM (Kasibhatla et al., 2007).
In the present study, we have investigated the involvement of PTP1B in
the deleterious effects of adiposity and metabolic damage in insulin sensi-
tive tissues using wild-type and PTP1B) ⁄ ) mice maintained on the same
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mixed genetic background (C57Bl ⁄ 6J · 129Sv ⁄ J) at 3 and 16 months
of age.
Results
PTP1B-deficient mice are protected against fat accumulation
and peripheral insulin resistance during aging
Insulin resistance in peripheral tissues, frequently associated with an
increase in body fat, progressively increases with age (Barbieri et al.,
2001), (Tchkonia et al., 2010). As PTP1B-deficient mice are resistant to
HFD-induced obesity (Elchebly et al., 1999; Klaman et al., 2000), we
investigated whether its absence would protect against the adiposity and
insulin resistance associated with aging. This study was performed in ani-
mals maintained on a normal chow diet for up to 16 months. In both mice
and rats, no differences in parameters constituting body composition,
including fat mass, have been observed between animals of 16 and
24 months of age (Escriva et al., 2007), (Quinn et al., 2010). Male wild-
type mice at 16 months of age (hereafter referred to as 16-month-old,
obese wild-type mice) displayed significant increases in total body weight,
percentage of fat content, fat mass and lean mass as compared to mice at
3 months of age (Fig. 1A). Consistent with this, insulin and glucose toler-
ance tests revealed impaired insulin sensitivity with moderate glucose
intolerance in these 16-month-old, obese wild-type mice as compared to
3-month-old controls (Fig. 1B). These alterations in 16-month-old, obese
wild-type mice were prevented in age-matched PTP1B) ⁄ ) mice (hereafter
referred to as 16-month-old, nonobese PTP1B) ⁄ ) mice), except the
increase in body weight because of a significant increase in lean mass.
Notably, no differences in fat content, insulin sensitivity, and glucose toler-
ance were found between 3- and 16-month-old PTP1B) ⁄ ) mice although
body weight was increased at 16 months because of enhanced lean mass.
Next, we performed a 2-h hyperinsulinemic–euglycemic clamp com-
bined with intravenous administration of [3-3H] glucose and [1-14C] 2-de-
oxyglucose in the four groups of mice (Fig. 1C). Although a small but not
significant increase was observed in whole-body glucose infusion rate and
hepatic glucose production (HGP) during the clamp in 3-month-old
PTP1B) ⁄ ) mice compared to 3-month-old wild-type mice, there was a sig-
nificant increase in tissue-specific glucose uptake in both white adipose tis-
sue (WAT) and brown adipose tissue (BAT). On the other hand, when 16-
month-old mice of both genotypes were compared with the correspond-
ing 3-month-old animals, glucose infusion rate decreased by 60% in 16-
month-old, obese wild-type mice, whereas this parameter only decreased
by 28% in 16-month-old, nonobese PTP1B) ⁄ )mice. Moreover, the signifi-
cant decreases observed in glucose uptake in skeletal muscle, WAT, and
BAT in 16-month-old, obese wild-type mice compared to 3-month-old
controls were not appreciated in 16-month-old, nonobese PTP1B) ⁄ )mice.
Accordingly with these data, while glycogen synthesis decreased and HGP
increased in 16-month-old, obese wild-type mice compared to 3-month-
old wild-type mice, no significant differences were found in these parame-
ters between 3- and 16-month-old PTP1B) ⁄ )mice.
As it has been reported that PTP1B deficiency improves beta-cell
function in IRS2) ⁄ ) diabetic mice (Kushner et al., 2004), we performed
histological analysis of the endocrine pancreas in wild-type and
PTP1B) ⁄ ) mice at 3 and 16 months. As expected for an insulin resis-
tant state, pancreatic sections from 16-month-old, obese wild-type
mice showed enlarged islets with a 2.5-fold increase in islet area.
Moreover, in these mice, insulin levels were significantly elevated com-
pared to 3-month-old wild-type mice (Fig. 2A,B). However, PTP1B
expression in pancreas was similar between both age groups of wild-type
mice (Fig. 2C). Notably, islet enlargement and hyperinsulinemia were
absent in 16-month-old, nonobese PTP1B) ⁄ ) mice (Fig. 2A,B). Fed glu-
cose levels were 130 ± 4 mg dL)1 (3-month-old wild-type),
119 ± 3 mg dL)1 (3-month-old PTP1B) ⁄ )), 141 ± 5 mg dL)1 (16-month-
old, obese wild-type), and 113 ± 4 mg dL)1 (16-month-old, nonobese
PTP1B) ⁄ )) (P = 0.045, 3-month-old PTP1B) ⁄ ) vs. 3-month-old wild-type;
P = 0.01, 16-month-old, obese wild-type vs. 3-month-old wild-type;
P = 0.02 16-month-old, nonobese PTP1B) ⁄ ) vs. 16-month-old, obese
wild-type).
PTP1B deficiency protects against inflammation and hypoxia
in white adipose tissue in age-associated obesity
As adipose tissue accretion and inflammation may be causatively linked
to insulin resistance, we hypothesized that PTP1B might modulate the
obesity-induced inflammation associated with aging. Thus, we first
assessed pro-inflammatory markers in WAT from the four groups of
mice. Histological examination of WAT showed a direct relationship
between fat accumulation (Fig. 1A) and adipocyte hypertrophy with the
mean adipocyte cross-sectional area being significantly higher in 16-
month-old, obese wild-type mice compared to age-matched nonobese
PTP1B) ⁄ ) mice (Fig. 3A). Moreover, immunohistochemical analysis of
F4 ⁄ 80 revealed clusters of adipose tissue macrophages (ATM) forming
crown-like structures exclusively in WAT of 16-month-old, obese wild-
type mice (Fig. 3A). Quantitative real-time PCR showed significant eleva-
tions in the expression of other pro-inflammatory markers such as CD68,
CD11c, and TNFa in these mice (Fig. 3B). In contrast, PTP1B) ⁄ ) mice pre-
sented smaller increases in these parameters with aging and the levels of
the above-mentioned pro-inflammatory markers were significantly lower
in 16-month-old, nonobese PTP1B) ⁄ ) mice than those of the age-
matched obese wild-type mice. Next, we investigated whether our
observations at the local tissue level were also reflected in serum levels of
pro-inflammatory cytokines and adipokines. As shown in Fig. 3C, serum
TNFa increased with aging in both genotypes of mice. Of note, the levels
of serum TNFa were significantly higher in 16-month-old, obese wild-
type mice as compared to age-matched nonobese PTP1B) ⁄ ) mice. How-
ever, serum levels of IL6 or resistin were similar between all the groups
of mice. Adiponectin levels were higher in 3-month-old PTP1B) ⁄ ) mice
as compared to the age-matched wild-type controls, but no differences
in this cytokine were detected between obese, wild-type and nonobese,
PTP1B) ⁄ ) mice at 16 months. Serum leptin levels increased with aging in
wild-type mice in proportion to adiposity. However, consistent with the
lower adiposity observed in 16-month-old, nonobese PTP1B) ⁄ ) mice,
levels of leptin were significantly lower in these mice as compared to
age-matched wild-type mice. Serum triglycerides (TG) were significantly
elevated in 16-month-old, obese wild-type mice as compared to
3-month-old wild-type control, but the levels in 16-month-old, nonobese
PTP1B) ⁄ ) mice were equivalent to their corresponding young animals
(Fig. 3D).
Recently, increased expression of p53 in WAT has been reported to be
involved in the development of diet-induced obesity and insulin resistance
(Minamino et al., 2009). Interestingly, a significant up-regulation of p53
was detected in WAT from 16-month-old, obese wild-type mice but not
in 16-month-old, nonobese PTP1B) ⁄ ) mice (Fig. 3E). Moreover, the
expression of FasL and Bid, two pro-apoptotic mediators of the death
receptor signaling implicated in the pro-inflammatory response (Wueest
et al., 2010), was increased in WAT from 16-month-old, obese wild-type
mice as compared to age-matched mice lacking PTP1B. Finally, enhanced
expression of HIF1a in WAT of 16-month-old, obese wild-type mice
suggested the presence of microvascular hypoxia, which was not
observed in 16-month-old, nonobese PTP1B) ⁄ ) mice.
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PTP1B deficiency protects against obesity-associated
activation of stress kinases and steatosis in the liver during
aging
As adipose tissue inflammation has been linked to histopathological
changes in the liver that reflect steatosis (Cancello et al., 2006), we next
addressed the possibility that loss of PTP1B, by reducing the inflammation
in WAT, ameliorates the development of fatty liver during aging-associ-
ated obesity. Histological examination of liver sections revealed higher
lipid accumulation in 16-month-old obese, wild-type mice as compared
to nonobese PTP1B-deficient mice of the same age (Fig. 4A). This was
associated with decreased hepatic TG in 16-month-old, nonobese
Fig. 1 Protein tyrosine phosphatase 1B (PTP1B)-deficient mice are protected against fat accumulation and insulin resistance during aging. Metabolic phenotyping of 3m-
PTP1B+ ⁄ +, 3m-PTP1B) ⁄ ), 16m-PTP1B+ ⁄ +, and 16m-PTP1B) ⁄ ) mice. (a) (Left panel) Body composition analyzed by dual-energy X-ray absorptiometry (DEXA) scan analysis
(n = 6 per genotype). (Right panel) Body weight, fat content, fat mass and lean mass (n = 6 per genotype). (b) (Left panel) insulin tolerance test (ITT) and (right panel) glucose
tolerance test (GTT) (n = 20–25 per genotype). Data corresponding to ITT and GTT tests in 3m-PTP1B) ⁄ ) vs. 3m-PTP1B+ ⁄ + are in agreement with a previous report (Klaman
et al., 2000). (c) Hyperinsulinemic–euglycemic clamp and tissue-specific glucose uptake studies (n = 6–8 per genotype). *P < 0.05, 3m-PTP1B) ⁄ ) vs. 3m-PTP1B+ ⁄ +;
•P < 0.05, ••P < 0.01 and •••P < 0.005, 16m-PTP1B+ ⁄ + vs. 3m-PTP1B+ ⁄ +; mP < 0.05, mmP < 0.01 and mmmP < 0.005, 16m-PTP1B) ⁄ ) vs. 16m-PTP1B+ ⁄ +; #P < 0.05 and
###P < 0.005, 16m-PTP1B) ⁄ ) vs. 3m-PTP1B) ⁄ ).
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PTP1B) ⁄ ) mice (Fig. 4B). In agreement with these data, expression levels
of genes involved in fatty acid synthesis such as Fasn and Srebf1 markedly
increased in the liver of 16-month, obese wild-type mice, but up-regula-
tion of these markers was absent in 16-month, nonobese PTP1B-deficient
mice that did not develop hepatic steatosis with aging (Fig. 4C).
To explore whether this obesity-dependent lipid accumulation during
aging may be related to the activation of stress kinases, we measured the
phosphorylation of JNK1 ⁄ 2, its substrate c-Jun and p38 MAPK kinase. The
results depicted in Fig. 4D demonstrate increased activation of these stress
kinases in livers from 16-month-old, obese wild-type mice compared with
3-month-old wild-type controls. Activation of these stress kinases was not
detected in 16-month-old mice lacking PTP1B that did not develop obesity
during aging. Moreover, phosphorylation of IRS1 ser307, which is related
to the negative feedback loop of JNK-mediated signaling (Sabio et al.,
2009), was increased only in the livers of 16-month-old, obese wild-type
mice.Conversely, no differences in thephosphorylation of theER stress kin-
ases PERK and eIF2a were observed between the livers of both genotypes
of mice at 16 months (results not shown), indicating that JNK is likely to
mediate the serine phosphorylation of IRS1 during age-associated obesity.
Aged PTP1B-deficient mice are protected against hepatic
insulin resistance
Various lines of evidence demonstrate that chronic activation of pro-
inflammatory pathways within insulin-sensitive cells can lead to the
deregulation of insulin signaling (Schenk et al., 2008). Consistent with
this notion, insulin-induced tyrosine phosphorylation of the IRb chain and
total (anti-phosphoTyr-associated) PI 3-kinase activity were decreased in
livers from 16-month, obese wild-type mice as compared to mice at
3 months (Figs 5A and S1). However, in 16-month-old, nonobese
PTP1B) ⁄ ) mice, activation of IR and PI 3-kinase-mediated insulin signaling
was comparable to the response of these mice at 3 months of age.
Downstream of PI 3-kinase, the phosphorylation of Akt at the catalytic
(Thr 308) and hydrophobic (Ser 473) sites was markedly reduced in the
livers of 16-month-old, obese wild-type mice but not in age-matched
PTP1B) ⁄ ) mice as compared with the corresponding controls at
3 months. Likewise, the ability of insulin to stimulate the phosphorylation
of Foxo1 was enhanced in 16-month-old, nonobese mice lacking PTP1B.
As we have previously reported enhanced insulin signaling in PTP1B-defi-
cient hepatocytes from 3-month-old mice compared to wild-type controls
(Gonzalez-Rodriguez et al., 2007), we analyzed this response in primary
hepatocytes from 16-month-old, obese wild-type mice and nonobese
mice lacking PTP1B. As a control, we prepared primary hepatocytes from
3-month-old mice of both genotypes. Figures 5B and S1 reveal that the
aging-associated attenuation of insulin-mediated phosphorylation of Akt
and Foxo1 in hepatocytes does not occur in hepatic cells lacking PTP1B.
Next, we investigated possible differences in the ability of insulin to
inhibit transcription of Pck1 and G6pc in primary hepatocytes from
16-month-old wild-type and PTP1B) ⁄ ) mice. As shown in the northern
blot analysis depicted in Figs 5B and S1, the down-regulation of Pck1 and
Fig. 2 Protein tyrosine phosphatase 1B (PTP1B) deficiency protects against b-cell hyperplasia and hyperinsulinemia during aging. Analysis of pancreata from 3m-PTP1B+ ⁄ +,
3m-PTP1B) ⁄ ), 16m-PTP1B+ ⁄ +, and 16m-PTP1B) ⁄ ) mice. (a) (Left panel) Representative staining with cresyl violet in pancreas sections (n = 4–5 per genotype). (Right panel)
Islet surface was calculated by mean cross-sectional area of multicelled islets from pancreas (n = 45–50 islets per pancreas from 4 to 5 animals per genotype). (b) (Left panel)
Representative anti-insulin immunostaining in pancreas sections. (Right panel) Serum levels of insulin (n = 10 per genotype). (c) (Left panel) Representative anti-PTP1B
immunostaining in pancreas sections (n = 3 per genotype). (right panel) Ptpn1 mRNA levels determined by real-time PCR (n = 5–6 per genotype). *P < 0.05 and •P < 0.005,
16m-PTP1B+ ⁄ + vs. 3m-PTP1B+ ⁄ +; mP < 0.05 and mmmP < 0.005, 16m-PTP1B) ⁄ ) vs. 16m-PTP1B+ ⁄ +.
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G6pc mRNAs by insulin was significantly reduced in hepatocytes from
16-month-old, obese wild-type mice as compared to the corresponding
3-month-old controls. In contrast, the inhibitory effect of insulin on Pck1
and G6pc mRNAs was preserved in hepatocytes from 16-month-old, non-
obese PTP1B) ⁄ ) mice.
Differential expression of negative modulators of insulin
signaling in the liver of 16-month-old, obese wild-type and
nonobese PTP1B-deficient mice
We assessed the possibility that the striking differences in insulin signaling
between 16-month-old obese, wild-type mice and nonobese, PTP1B-defi-
cient mice could reflect differential expression of critical negative modula-
tors of the early steps of insulin signaling. PTP1B was a logical candidate
given its ability to directly dephosphorylate the IR (Salmeen et al., 2000).
Consistent with its role in regulating insulin sensitivity, PTP1B protein and
mRNA levels were significantly up-regulated in the livers of 16-month-old,
obese wild-type mice compared to mice at 3 months (Figs 5C,D and S1).
PTP1B protein levels were also up-regulated in primary hepatocytes from
16-month-old, obese wild-type mice as compared to hepatocytes from 3-
month control mice (Figs 5C and S1). Importantly, PTP1B activity was aug-
mented in liver extracts from 16-month-old, obese wild-type mice com-
pared with the phosphatase activity of 3-month-old mice (Fig. 5E).
Regarding other phosphatases that negatively modulate insulin signaling,
Fig. 3 PTP1B deficiency protects against inflammation and hypoxia in WAT in age-associated obesity. Analysis of WAT pads from 3m-PTP1B+ ⁄ +, 3m-PTP1B) ⁄ ), 16m-
PTP1B+ ⁄ +, and 16m-PTP1B) ⁄ ) mice. (a) (Left panel) Representative immunostaining with F4 ⁄ 80 in WAT sections (n = 7–8 per genotype). (Right panel) Adipocyte surface was
calculated by mean cross-sectional area of adipocytes from epididymal WAT (n = 25 adipocytes per WAT pad from six animals per genotype). (b) F4 ⁄ 80, Cd68, Tnf, and
Cd11c mRNA levels determined by real-time PCR (n = 9 per genotype). (c) Serum levels of the indicated cytokines (n = 8–12 per genotype). (d) Serum levels of triglycerides
(n = 8 per genotype). (e) Western blot analysis of WAT pad extracts with the indicated antibodies (n = 6–8 per genotype). *P < 0.05, 3m-PTP1B) ⁄ ) vs. 3m-PTP1B+ ⁄ +;
•P < 0.05, ••P < 0.01 and •••P < 0.005, 16m-PTP1B+ ⁄ + vs. 3m-PTP1B+ ⁄ +; mP < 0.05 and mmmP < 0.005, 16m-PTP1B) ⁄ ) vs. 16m-PTP1B+ ⁄ +; #P < 0.05, 16m-PTP1B) ⁄ ) vs.
3m-PTP1B) ⁄ ).
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expressionof thephosphatidylinositolphosphatasePTENwasup-regulated
in both wild-type and PTP1B) ⁄ ) mice with aging as compared to 3-month-
old control mice (Figs 5C and S1) mice, whereas no differences were found
in theexpression of the tyrosinephosphataseSHP2 (resultsnot shown).
Elevated expression of p85a regulatory subunit of PI 3-kinase induces
competition with p85a-p110 dimmers, thereby inhibiting insulin signaling
(Mauvais-Jarvis et al., 2002). Thus, p85a constitutes a critical node in the
insulin-signaling cascade. Levels of p85a were significantly lower in liver
extracts from PTP1B) ⁄ ) mice than those of wild-type mice at both ages.
Finally, the expression of p53 was up-regulated in the liver of 16-month-
old, obese wild-type mice compared to control mice at 3 months, but
this effect was absent in age-matched nonobese PTP1B) ⁄ ) mice (Figs 5C
and S1).
Elevated expression of negative modulators of insulin
signaling in skeletal muscle from 16-month-old,
obese wild-type mice and protection by PTP1B deficiency
As we have demonstrated that PTP1B deficiency has beneficial effects on
insulin resistance in 16-month-old mice (Fig. 1C), the effect of PTP1B
deficiency in insulin signaling in skeletal muscle was evaluated. Insulin-
induced Akt ⁄ Foxo1 phosphorylation was markedly attenuated in skeletal
Fig. 4 PTP1B deficiency protects against obesity-associated activation of stress kinases and steatosis in the liver during aging. Analysis of livers from 3m-PTP1B+ ⁄ +, 3m-
PTP1B) ⁄ ), 16m-PTP1B+ ⁄ +, and 16m-PTP1B) ⁄ ) mice. (a) Representative staining with Hematoxylin & Eosin and Oil red O in liver sections (n = 6 per genotype). (b) Hepatic
triglycerides content (n = 6 per genotype). (c) Fasn and Srebf1 mRNA levels determined by real-time PCR (n = 8 per genotype). (d) Western blot analysis of liver extracts
with the indicated antibodies (n = 6–8 per genotype). •P < 0.05 and ••P < 0.01, 16m-PTP1B+ ⁄ + vs. 3m-PTP1B+ ⁄ +; mP < 0.05 and mmmP < 0.005, 16m-PTP1B) ⁄ ) vs.
16m-PTP1B+ ⁄ +.
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muscle from 16-month-old, obese wild-type mice as compared to mice at
3 months, but was normal in 16-month-old, nonobese PTP1B) ⁄ ) animals
(Figs 5F and S2). Similar to our observations in liver, both mRNA and pro-
tein levels of PTP1B increased in skeletal muscle of 16-month-old, obese
wild-type mice (Figs 5G,H and S2). PTEN was also up-regulated in skeletal
muscle of obese wild-type and nonobese PTP1B) ⁄ ) mice at 16 months as
compared to the 3-month-old mice of both genotypes (Figs 5H and S2),
whereas no differences were found in the expression of SHP2 (results not
(A)
(B)
(C)
(D) (E)
(F) (G)
(H)
Fig. 5 PTP1B deficiency recovers insulin signaling in liver and muscle from 16-month-old mice. (a) Analysis of insulin response and its signaling pathways in liver from
3m-PTP1B+ ⁄ +, 3m-PTP1B) ⁄ ), 16m-PTP1B+ ⁄ +, and 16m-PTP1B) ⁄ ) mice. Quantification of Western blot analysis of liver extracts (n = 8 per genotype) performed with the
indicated antibodies. Quantification of anti-pTyr-associated PI3K activity in liver extracts (n = 8 per genotype) (see Fig. S1). (b) (Left panel) Quantification of Western blot
analysis of insulin signaling in primary hepatocytes (3 mice per genotype). (Right panel) Quantification of the insulin effect on the inhibition of cAMP ⁄ Dex-stimulated Pck1 and
G6pc mRNA by northern blot analysis in primary hepatocytes (three mice per genotype). Increased insulin signaling in liver and hepatocytes of 3m-PTP1B) ⁄ ) compared to
3m-PTP1B+ ⁄ + agrees with previous reported data (Haj et al., 2005) (Gonzalez-Rodriguez et al., 2007). (c) Quantification of Western blot analysis of liver extracts (n = 8 per
genotype) with the indicated antibodies. PTP1B expression was also analyzed in primary hepatocytes (three mice per genotype). (d) Ptpn1 mRNA levels determined by
real-time PCR from livers (n = 12 per genotype). (e) PTP1B enzymatic activity in liver extracts (n = 5 per genotype). (f) Analysis of insulin response and its signaling pathways in
skeletal muscle from 3m-PTP1B+ ⁄ +, 3m-PTP1B) ⁄ ), 16m-PTP1B+ ⁄ +, and 16m-PTP1B) ⁄ ) mice. Quantification of Western blot analysis of skeletal muscle extracts with the
indicated antibodies (n = 6 per genotype). (g) Ptpn1 mRNA levels determined by real-time PCR from skeletal muscle (n = 12 per genotype). (h) Quantification of Western blot
analysis of skeletal muscle extracts with the indicated antibodies. *P < 0.05, 3m-PTP1B) ⁄ ) vs. 3m-PTP1B+ ⁄ +; •P < 0.05 and ••P < 0.01, 16m-PTP1B+ ⁄ + vs. 3m-PTP1B+ ⁄ +;
mP < 0.05, mmP < 0.01 and mmmP < 0.005, 16m-PTP1B) ⁄ ) vs. 16m-PTP1B+ ⁄ +. #P < 0.05, 16m-PTP1B) ⁄ ) vs. 3m-PTP1B) ⁄ ).
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shown). Finally, PTP1B deficiency prevented the age-related increase in
p53 level, as well as decreased levels of p85a-PI 3-kinase regulatory sub-
unit in skeletal muscle of 16-month-old mice (Figs 5H and S2).
Effect of PTP1B deficiency on energy expenditure in
16-month-old mice
To determine the cause of decreased adiposity and resistance to age-
associated obesity in PTP1B) ⁄ ) mice, we examined food intake and
energy expenditure (EE) parameters. No significant differences were
found in daily food intake between PTP1B) ⁄ ) and wild-type animals
although there was a trend toward a decrease in PTP1B-deficient mice at
both ages (Fig. 6A). These data suggested that EE may be increased in
16-month-old, nonobese PTP1B) ⁄ ) mice. Thus, we performed indirect
calorimetry to assess EE and substrate oxidation. Oxygen consumption
(VO2) was elevated in 16-month-old, nonobese PTP1B) ⁄ ) mice as
compared to age-matched obese wild-type mice during light and dark
cycles albeit significant differences between both genotypes at 3 months
were found only in the dark cycle. Energy expenditure was also increased
in 16-month-old, nonobese PTP1B-deficient mice compared to obese
wild-type mice at the same age during light and dark periods, and, simi-
larly, the corresponding values of 3-month-old PTP1B) ⁄ ) mice were sta-
tistically significant from the 3-month-old wild-type mice only in the dark
period. Of note, no differences between genotypes and age were noted
in respiratory quotient (RQ), indicating that PTP1B deficiency does not
alter fuel selection between fatty acids and carbohydrate during aging.
Finally, we determined differences in expression levels of genes
involved in fatty acid oxidation. In liver (Fig. 6B), there was a significant
increase in Ucp2 and Pgc1a levels in mice lacking PTP1B as compared to
the wild-type controls at 3 and 16 months. In skeletal muscle, Ucp3 and
Pgc1b were increased in 16-month-old, nonobese PTP1B) ⁄ ) mice as
compared to the obese wild-type mice of the same age (Fig. 6C).
Discussion
The development of insulin resistance that occurs with aging has been
attributed to the increased prevalence of risk factors such as sedentary
lifestyle that leads to obesity (Lechleitner, 2008). As lifespan is actually
extended in Western countries, therapeutic interventions are needed
to reduce morbidity and improve quality of life in an elderly popula-
tion. The present study has demonstrated that deficiency of PTP1B
ameliorates peripheral insulin resistance, adiposity, inflammation, hy-
perleptinemia, hyperinsulinemia, and islet hyperplasia in mice at
16 months of age, implicating this enzyme as a key player in the
Fig. 6 Effect of PTP1B deficiency on energy expenditure (EE) in 16-month-old mice. Analysis of EE parameters of 3m-PTP1B+ ⁄ +, 3m-PTP1B) ⁄ ), 16m-PTP1B+ ⁄ +, and 16m-
PTP1B) ⁄ ) mice (a). Daily food intake (n = 10 per genotype). respiratory quotient, VO2, and EE determined by indirect calorimetry (n = 4 per genotype). Increased EE in 3m-
PTP1B) ⁄ ) compared to 3m-PTP1B+ ⁄ + agrees with previous data (Klaman et al., 2000). (b) Ucp2, Pgc1a, Pgc1b, Ppara, and Cpt1a mRNA levels determined by real-time PCR
from livers (n = 8 per genotype). (c) Ucp3, Pgc1a, Pgc1b, Ppara, and Cpt1b mRNA levels determined by real-time PCR from skeletal muscles (n = 8 per genotype). *P < 0.05,
3m-PTP1B) ⁄ ) vs. 3m-PTP1B+ ⁄ +; mP < 0.05, 16m-PTP1B) ⁄ ) vs. 16m-PTP1B+ ⁄ +.
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development of obesity-associated metabolic alterations during aging.
Importantly, the leanness of 16-month-old PTP1B) ⁄ ) mice is associated
with increased whole-body EE and fatty acid oxidation but not with a
reduction in daily food intake.
The molecular mechanisms underlying the association of obesity, insulin
resistance, and chronic low-grade inflammation during aging are of critical
importance for the development of new drugs to treat metabolic diseases
in an elderly population. Our data show that fat mass is increased in 16-
month-old wild-type mice; moreover, we observed enhanced adipocyte
hypertrophy, crown-like structures, pro-apoptotic, and pro-inflammatory
markers in WAT of these mice. Increased expression of pro-inflammatory
genes in WAT and up-regulation of PTP1B have been described in mice fed
for 20 weeks with HFD. This has been attributed to a TNFa-mediated
increase in PTP1B transcription via nuclear factor jB (NFjB) activation (Za-
bolotny et al., 2008). However, in the present study, we did not observe
differences in the expression of PTP1B between WAT of 3- and 16-month-
old wild-type mice maintained on a chow diet (results not shown),
although TNFa levels were increased at 16 months of age. This suggests
that the pro-inflammatory phenotype of WAT in 16-month-old, obese
wild-type mice occurs without an elevation of PTP1B. By contrast, mRNA,
protein levels, and activity of PTP1B were elevated in liver and muscle of
wild-type mice at 16 months compared to 3-month-old animals, perhaps
owing to elevated levels of circulating TNFa. These findings imply that
PTP1B expression increases with obesity during aging in a tissue-specific
manner. Consistent with this, we have reported that PTP1B plays a promi-
nent role in mediating the deleterious effects of TNFa in skeletal muscle
(Nieto-Vazquez et al., 2007). Therefore, the differential effects of age-
related obesity on PTP1B expression in these tissues may suggest that WAT
PTP1B might not increase in obesity because of compensatory adapta-
tions. Nevertheless, PTP1B deficiency protects from WAT accumulation
during aging, thereby preventing the expression and secretion of pro-
inflammatory adipokines including TNFa, which are associated with path-
ological changes in peripheral tissues. In agreement with these data, insu-
lin responsiveness of WAT, as assessed by stimulation of glucose transport
during the hyperinsulinemic–euglycaemic clamp, is higher in 16-month-
old, nonobese PTP1B) ⁄ ) mice as compared to age-matched obese wild-
type animals. These results differ from published data (Ruffolo et al.,
2007) showing the lack of improvement of insulin signaling in adipocytes
from 16-week-old PTP1B) ⁄ ) mice. This was because of increased basal
S6K1 activity which leads to IRS1 serine phosphorylation and disruption of
PI 3-kinase activation, thereby limiting the effects of insulin on fatty acid
uptake and lipolysis (Um et al., 2004). The age of the study animals might
account for the differences obtained between this study (Ruffolo et al.,
2007) and our present data. Our results demonstrate that the enhanced
insulin sensitivity of WAT from 16-month-old PTP1B) ⁄ ) mice correlates
with protection against inflammation and apoptotic-like features. Of note,
PTP1B deficiency also conferred protection against the decrease in glucose
uptake in BAT, suggesting its involvement in modulating insulin actions
during age-related obesity in both types of fat.
The development of hypoxia in WAT has been described in genetic
models of obesity in rodents (Ye et al., 2007), (Rausch et al., 2008).
In vitro, overexpression of HIF1a impairs insulin signaling in 3T3L1 and
human adipocytes (Regazzetti et al., 2010). In light of these data, our
study suggests that fat accumulation during aging is associated with
increased expression of HIF1a, which is prevented by PTP1B deficiency.
As hypoxia increases oxidative stress which, in turn, attracts macrophages
and exacerbates inflammation (Rausch et al., 2008), inhibition of PTP1B
might provide therapeutic benefit for insulin resistance and obesity.
Recent evidence suggests a potential relationship between cellular
aging signals in adipose tissue and metabolic disorders. In this regard, Min-
amino et al., (2009) have shown that excess caloric intake promotes
senescence-like changes in adipose tissue of young mice including
increased oxidative stress and the expression of the tumor suppressor p53.
Indeed, our results demonstrate clearly that p53 protein levels increase in
WAT, liver and skeletal muscle of 16-month-old wild-type mice but not in
mice lacking PTP1B. Given that PTP1B-deficient mice do not develop obes-
ity with age, our findings suggest that preservation of normal p53 expres-
sion in insulin sensitive tissues is related to their lean phenotype.
Elevation in circulating fatty acids and pro-inflammatory adipokines
which originate from WAT reduces insulin sensitivity in liver and skeletal
muscle (Olefsky, 2008). However, the molecular mechanisms underlying
this deleterious cross-talk are currently not well understood. Adipose tis-
sue inflammation has been correlated with hepatic steatosis in humans
(Cancello et al., 2006). In our study, the presence of obesity-induced
inflammatory milieu was manifested by the accumulation of TG and
marked increases in JNK, c-Jun and p38 MAPK phosphorylation in livers
of 16-month wild-type mice. Activation of these stress kinases has been
described in primary hepatocytes stimulated with palmitate (Akazawa
et al., 2010) or TNFa (Gonzalez-Rodriguez et al., 2009) and negatively
modulates insulin signaling (Aguirre et al., 2000). Consequently, in the
liver of 16-month-old, obese wild-type mice, hepatic insulin action,
including inhibition of gluconeogenic genes Pck1 and G6pc, was
impaired. As stated above, PTP1B expression and activity were elevated in
the livers and primary hepatocytes of 16-month-old, obese wild-type
mice, most likely owing to elevated inflammation. Thus, in these mice,
the negative cross-talk on insulin signaling elicited by JNK on IRSs proteins
and by PTP1B on the IR might synergize to induce hepatic insulin resis-
tance. Ablation of PTP1B is associated with reduced activation of stress
kinases, decreased lipogenic gene expression and fatty liver and recovery
of hepatic insulin sensitization. Likewise, in skeletal muscle, obesity-
mediated impairment of insulin signaling during aging was reverted in
PTP1B-deficient mice. Collectively, our results demonstrated that the
obesity-related inflammation and insulin resistance which generate a
negative endocrine cross-talk between WAT and peripheral tissues during
aging (Olefsky, 2008; Olefsky & Glass, 2010) are prevented by inhibition
of PTP1B. Moreover, our observations suggest that the positive effects of
PTP1B deficiency on inflammation and insulin resistance are because of
the prevention of obesity through increased EE which may reflect the
enhanced sensitivity to leptin in the hypothalamus of these mice (Klaman
et al., 2000). We observed a small decline of glucose infusion rate during
the clamp study in 16-month vs. 3-month-old PTP1B-deficient mice, sug-
gesting an effect of aging, independent of obesity, on whole-body insulin
sensitivity. However, none of the tissue-specific measures of insulin action
(glucose uptake in skeletal muscle and fat) were significantly different
between the two PTP1B-deficient age groups of mice. On the other hand,
as PTP1B is a critical negative modulator of the insulin-signaling cascade,
a direct role of PTP1B on insulin signaling pathways in the liver, skeletal
muscle, and brain should also not be excluded.
Experimental procedures
Reagents
Fetal serum (FS) and culture media were obtained from Invitrogen. Insulin
for cell culture (I-0516) was from Sigma Aldrich (Madrid, Spain). Human
regular insulin for animal experiments (Actrapid, 775502) was purchased
from Novo Nordisk (Novo Alle´, Bagsvaerd, Denmark). Protein A-agarose
was from Roche Diagnostics (Indianapolis, IN, USA). [c32P]-ATP (3000 c),
[a32P]-dCTP (3000 Ci mmol)1) and cDNA labeling kit were from GE
Healthcare (Little Chalfont, Buckinghamshire, UK).
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Antibodies
Anti-phospho-Foxo1 (Ser 256) (#9461), anti-phospho-Akt (Thr308)
(#2965), anti-Akt (#9272), anti-phospho JNK (Thr183 ⁄ Tyr185) (#4668),
anti-phospho-c-Jun (Ser73) (#9164), anti-phospho p38 MAPK
(Thr180 ⁄ Tyr182) (#9211) and anti-p38 MAPK (#9212) antibodies were
from Cell Signaling Technology (Danvers, MA, USA). Anti-Bid (Ref. AF860)
antibody was from R&D Systems (Minneapolis, MN, USA). Anti-FasL (Ref.
610410) and Anti-HIF1a (Ref. 610959) antibodies were from BD Bioscienc-
es PharMingen (San Diego, CA, USA). The anti-phospho-Akt (Ser473) (sc-
7985), anti-PTEN A2B1 (sc-7974), anti-IR b (sc-711), anti-phospho-IR b
(Tyr1162 ⁄ Tyr1163) (sc-25103-R), anti-JNK (sc-571), anti-c-Jun (sc-45) and
anti-phospho-Tyr for immunoprecipitations (Py20, sc-508) antibodies
were from Santa Cruz Biotechnology (Palo Alto, CA, USA). The anti-IRS1
(06-248), anti-p85a (06-195), anti-PTP1B (07-088), anti-phospho-IRS1
(Ser307) (07-247), anti-phospho-Tyr (clone 4G10, 05-321) and anti-SHP2
(06-118), antibodies were obtained from Upstate (Millipore Corporation,
Billerica, MA, USA). The anti-p53 antibody (Ref. OP03) was from Calbio-
chem (Merck KGaA, Darmstadt, Germany) or Cell Signalling Technology
(#2524). The anti-b-actin antibody (A-5441) was from Sigma-Aldrich.
Animals
Wild-type (PTP1B+ ⁄ +) and PTP1B-deficient (PTP1B) ⁄ )) mice were
obtained from Abbott Laboratories as previously described (Klaman et al.,
2000), (Nieto-Vazquez et al., 2007), (Gonzalez-Rodriguez et al., 2010).
3-month-old PTP1B+ ⁄ + (3m-PTP1B+ ⁄ +), 3-month-old PTP1B) ⁄ ) (3m-
PTP1B) ⁄ )), 16-month-old PTP1B+ ⁄ + (16m-PTP1B+ ⁄ +) and 16-month-old
PTP1B) ⁄ ) mice (16m-PTP1B) ⁄ )) were used throughout this study. Mice
were maintained on the same mixed genetic background
(C57Bl ⁄ 6J · 129Sv ⁄ J), fed a standard chow diet ad libitum and had free
access to drinking water. All animal experimentation was conducted in
accordance with accepted standards of animal care.
Metabolic measurements
For measuring fed and fasted (20–24 h fast) glucose levels, blood was
obtainedfromthe tail veinandglucoseconcentrationsweremeasuredwith
anAccu-CheckAvivaglucometer(Roche). Intraperitonealglucosetolerance
tests (GTT) were performed on mice fasted for 20–24 h and injected with
2 g D-glucose per kg. Blood glucose was measured at 30, 60, 90, and
120 minafter injection. Intraperitoneal insulintolerancetests(ITT)wereper-
formedon4 hfastedmice injectedwith0.75 U kg)1humanregular insulin,
andblood glucosewasmeasuredat 15, 30,45, 60, and120 minafter injec-
tion.AnimalsweresubjectedtoDEXAscananalysis infedconditionstoavoid
weight loss induced by overnight fasting. Animals were weighed and
sedated under isoflurane anesthesia and scanned in toto using a small ani-
malDEXAscanner(pDEXA;NorlandStratecMedizintechinikGmbH,Birken-
feld, Germany). This study was performed at the NMR Unit (Complutense
University, Spain). Fat and lean mass were measured on anesthetized mice
usinganEchoMRI-100analyzer (EchoMedical Systems,Houston,TX, USA).
Datawereanalyzedbythesoftwaresuppliedbythemanufacturer.
Hyperinsulinemic–euglycemic clamp
This study was performed at the UMass Mouse Phenotyping Center and
approved by UMass Medical School IACUC. After an overnight fast, a 2-h
hyperinsulinemic–euglycemic clamp was conducted in awake mice with a
continuous insulin infusion rate of 2.5 mU kg)1 min)1 (Kim et al., 2004).
Basal metabolic rate and insulin-stimulated whole-body glucose turnover
were estimated using a continuous infusion of [3-3H] glucose (PerkinEl-
mer, Boston, MA, USA) for 2 h before the clamps (0.05 lCi min)1) and
throughout the clamps (0.1 lCi min)1), respectively. Whole-body glyco-
gen synthesis is calculated as the difference between whole-body glucose
turnover and glycolysis. To estimate insulin-stimulated glucose uptake in
individual tissues, 2-deoxy-D-[1-14C] glucose (2-[14C] DG; PerkinElmer,
Boston, MA, USA) was administered as a bolus (10 lCi) at 75 min after
the start of the clamps. At the end of the clamp, tissues (gastrocnemius,
white and brown adipose and liver) were taken for biochemical analysis.
Indirect calorimetry
Indirect calorimetry was performed following standard methods using
Oxylet System metabolic chambers (Panlab Harvard Apparatus, Barce-
lona, Spain) at the Phenotyping Unit (IIS Aragon, Spain). Mice were in the
measurement cages 12 h previous to data recording. Room temperature
was 23 C, and light ⁄ dark cycles were of 12 h. Volume of consumed O2
(VO2) and eliminated CO2 (VCO2) were recorded every 24 min. Respira-
tory quotient was calculated as: RQ = VCO2 ⁄VO2. Energy expenditure
was calculated as: EE = (3.815 + (1.232xRQ)) · VO2 · 1.44). Daily body
weight and food intake were manually measured.
Insulin-signaling studies
Four hour fasted mice were intraperitoneally injected with PBS or
0.75 U kg)1 of human regular insulin and killed 15 min later. Then,
peripheral tissues (liver, muscle – gastrocnemius – and epididymal
WAT) were removed, and total protein extracts were prepared as
previously described (Gonzalez-Rodriguez et al., 2010).
Primary culture of adult hepatocytes
Hepatocytes were isolated from nonfasting male mice by perfusion with
collagenase as described (Benveniste et al., 1998), (Gonzalez-Rodriguez
et al., 2010). Cells were plated in 60-mm dishes (Falcon; BD Biosciences,
Franklin Lakes, NJ, USA) and cultured in William¢s E medium supple-
mented with 20 ng mL)1 EGF, 100 U mL)1 penicillin, 100 lg mL)1
streptomycin and 10% FS for 48 h. Cells were serum starved for 4–6 h
and further stimulated with 1 or 10 nM insulin for 10 min.
RNA extraction from primary hepatocytes and
northern blot analysis
Primary hepatocytes were cultured in serum-free medium for 4–6 h and
further stimulated with dex ⁄ cAMP (0.5 mM dibutyril cAMP plus 1 lM
dexamethasone) in the absence or presence of insulin (10 nM) for 6 h. At
the end of the culture time, RNA was isolated and submitted to northern
blot analysis. Total RNA was isolated from primary hepatocytes with Trizol
(Invitrogen, Grand Island, NY, USA) and submitted to northern blot analy-
sis as previously described (Valverde et al., 2003), (Gonzalez-Rodriguez
et al., 2010). Blots were hybridized with cDNA probes for Pck1 and G6pc.
Membranes were subjected to autoradiography, and relative quantifica-
tion of the hybridization signals was performed by densitometric scan-
ning of the autoradiograms.
Analysis of serum cytokines and hormones
Serum analysis was performed as described (Banno et al., 2010). Serum
IL6 and TNFa were measured using the Multiplex Kit (Linco, Millipore
Corporation) following manual instructions. Serum insulin, leptin, resistin,
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and adiponectin were determined by ELISA (Linco, Millipore) following
manual instructions.
Determination of triglyceride (TG) levels
Triglyceride levels were determined in plasma and liver extracts by enzy-
matic methods with specific kits from Biosystems (Barcelona, Spain).
Preparation of tissue extracts, immunoprecipitation,
PI 3-kinase activity and western blot
All these methods have been previously described (Valverde et al., 1997).
PTP1B phosphatase activity
Protein tyrosine phosphatase 1B phosphatase activity was determined by
measuring phosphate release using a synthetic monophosphotyrosyl-con-
taining peptide and the malachite green assay (Millipore) as previously
described (Gonzalez-Rodriguez et al., 2010).
Quantitative real-time PCR analysis and primer sequence
Total RNA extraction from islets was performed with an RNAspin kit
(HealthCare, Little Chalfont, Buckinghamshire, UK) and from liver, muscle
and epididymal fat pads with Trizol (Invitrogen). Total RNA was reverse-
transcribed using a SuperScriptTM III First-Strand Synthesis System for
qPCR following manufacturer’s indications (Invitrogen). qPCR was per-
formed with an ABI 7900 sequence detector using the SyBr Green
method and d(N)6 random hexamer with the primers indicated.
The primers used in the real-time RT–PCR were the following:
Tnf, Fw 5¢CATCTTCTCAAAATTCGAGTGA3¢ and Rv 5¢TGGGAGTAGA
CAAGGTACAAC3¢
F4 ⁄ 80, Fw 5¢CTTTGGCTATGGGCTTCCAGTC3¢ and Rv 5¢GCAAGGAG
GACAGAGTTTATCGTG3¢
Cd68, Fw 5¢CAAGGTCCAGGGAGGTTGTG3¢ and Rv 5¢CCAAAGG
TAAGCTGTCCATAAGGA3¢
Cd11c, Fw 5¢GCCCAGGGATATGTTCACAGC3¢ and Rv 5¢ACACAG
TGTGCTCCAGTATGA3¢
Fasn, Fw 5¢GCCCAGACAGAGAAGAGGCA3¢ and Rv 5¢CTGA
CTCGGGCAACTTCCC3¢
Serbf1, Fw 5¢TAGAGCATATCCCCCAGGTG3¢ and Rv 5¢GGTACGGGC
CACAAGAAGTA3¢
Ucp2, Fw 5¢GATCTCATCACTTTCCCTCTGGATA3¢ and Rv 5¢CCCTT
GACTCTCCCCTTGG3¢
Ucp3, Fw 5¢ACTCCAGCGTCGCCATCAGGATTCT3¢ and Rv 5¢TAAACA
GGTGAGACTCCAGCAACTT3¢
Pgc1a, Fw 5¢AAGTGTGGAACTCTCTGGAACTG3¢ and Rv 5¢GGGT
TATCTTGGTTGGCTTTATG3¢
Pgc1b, Fw 5¢GCTCTGACGCTCTGAAGGAC3¢ and Rv 5¢AAGGGCTT
GGGCAATCCTC3¢
Ppara, Fw 5¢AGAGCCCCATCTGTCCTCTC3¢ and Rv 5¢ACTGGTAG
TCTGCAAAACCAAA3¢
Cpt1a, Fw 5¢TCAATCGGACCCTAGACACC3¢ and Rv 5¢ CTTTCGAC
CCGAGAAGACCT3¢
Cpt1b, Fw 5¢CAAGTCATGGTGGGCAACTA3¢ and Rv 5¢GCTGC
TTGCACATTTGTGTT3¢
18s, Fw 5¢AGTCCCTGCCCTTTGTACACA3¢ and Rv 5¢ GCCTCACTA
AACCATCCAATCG3¢
Primer–probe sets for mouse Ptpn1 were purchased as predesigned
TaqMan gene expression assays and run as per the manufacturer’s
instructions (Applied Biosystems, Foster City, CA, USA).
Islet morphometry, immunohistochemistry, and
immunofluorescence
Pancreata were fixed with 4% paraformaldehyde and cryoprotected in
PBS containing 30% sucrose. Cryostat sections (10 lm) were cut and
kept at )80 C until used. Sections were brought to room temperature,
permeabilized with methanol for 2 min at )20 C and stained with cre-
syl violet. Islets area was measured by acquiring images at 40· from adja-
cent nonoverlapping images of sections using a Nikon Eclipse 90i
microscope. Islets area was analyzed with the IMAGE J software. For insu-
lin immunostaining, sections were treated with 5% normal goat serum
and incubated with a guinea pig anti-human insulin antibody (Linco,
Millipore Corporation). Immunodetection was carried out with a goat
anti-guinea pig fluorescence-tagged antibody. Images were taken using
a Leica TCS SP5 confocal microscope. PTP1B staining was performed as
previously described in the study by Gonzalez-Rodriguez et al. (2010).
The protocol for islet isolation is detailed in the study by Hennige et al.
(2003).
Liver histology
Samples of liver were fixed with 4% paraformaldehyde and cryoprotect-
ed in PBS containing 30% sucrose. Cryostat sections (10 lm) were cut
and kept at )80 C until used. Liver sections were stained with Hematox-
ylin & Eosin and Oil red O.
Statistical analysis
The data are presented as the mean ± SEM. Statistical analysis was
carried out with SPSS (v.12) software (IBM Coorporation, Armonk, NY,
USA). The statistical significance was estimated with a multivariate analy-
sis of variance (ANOVA) or two-tailed Student¢s t-test in hyperinsulinemic–
euglycemic clamp studies. Statistical significance was considered at
P < 0.05.
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